LLY Stephen F Fry sells $2.0M worth of shares
Jan 03, 2026, 5:37 PM
0.00%
What does LLY do
Eli Lilly & Co., headquartered in Indianapolis, employs 43,000 staff and develops various pharmaceutical products, including diabetes, oncology, immunology, and neuroscience therapies, alongside radiopharmaceuticals through its subsidiary POINT Biopharma. The company manufactures and distributes products in the U.S., Europe, and Asia.
Stephen F Fry sold 14,657 shares of LLY on 30 March at $137.23 per share, worth a total of $2.0M. They now own 110,572 LLY shares, or a 12% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.